Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A tags : Bioscience save search
Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 2.7%
H: 1.41%
C: 0.0%
year bioscience financial results
Jushi Holdings Inc. Announces Opening of Relocated Dispensary in Mount Pocono, Pennsylvania through its Subsidiary, Franklin Bioscience – NE LLC
Published: 2024-01-10 (Crawled : 12:30) - globenewswire.com
JUSHF | $0.6763 2.74% 40K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -8.98%
bioscience
Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights
Published: 2023-11-22 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
bioscience financial results
Satellos Bioscience Enters Into an Agreement with ICP Securities Inc. to Provide Market Making Services
Published: 2023-09-07 (Crawled : 22:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
services bioscience agreement market
Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights
Published: 2023-08-29 (Crawled : 13:30) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
bioscience financial results
TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite
Published: 2023-08-21 (Crawled : 19:00) - prnewswire.com
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 3.33%
H: 0.0%
C: 0.0%
bioscience
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH
Published: 2023-08-21 (Crawled : 13:00) - globenewswire.com
CHNC | $0.0004 575.0% 860K
|
n/a
| Email alert
Add to watchlist
cannabis change approval construction bioscience international china
Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 5.78%
H: 2.07%
C: 2.07%
sat-3153 fda drug bioscience designation duchenne
Twist Bioscience and Cancer Research Horizons Enter into … – Business Wire
Published: 2023-07-18 (Crawled : 13:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.18%
H: 0.83%
C: 0.28%
business bioscience cancer research
Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan
Published: 2023-06-30 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 0.0%
H: 11.35%
C: 3.05%
bioscience meeting results
Satellos Bioscience Announces Appointment of Chief Medical Officer
Published: 2023-06-07 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 0.55%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
bioscience medical
Satellos Bioscience Announces Grant of Stock Options
Published: 2023-06-01 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: -6.67%
H: 0.0%
C: 0.0%
bioscience grant
Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights
Published: 2023-05-31 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 12.2%
H: 0.0%
C: 0.0%
bioscience financial results
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Published: 2023-05-17 (Crawled : 22:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
bioscience
Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy
Published: 2023-05-17 (Crawled : 14:20) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
drug candidate bioscience duchenne
Satellos Bioscience Inc. Announces Filing of Final Short Form Prospectus for Proposed Offering of Common Shares
Published: 2023-05-11 (Crawled : 15:20) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: -0.02%
H: 0.0%
C: -10.99%
bioscience offering
Satellos Bioscience Inc. Announces Pricing of Public Offering
Published: 2023-04-19 (Crawled : 15:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: -0.19%
H: 7.82%
C: 7.82%
bioscience offering
Satellos Bioscience Inc. Announces Public Offering of Common Shares
Published: 2023-04-18 (Crawled : 23:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
bioscience offering
Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights
Published: 2023-03-31 (Crawled : 17:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
| Email alert
Add to watchlist
year bioscience financial results
Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures
Published: 2023-03-30 (Crawled : 19:00) - biospace.com/
MSCLF | $0.3407 18.14% 1.2K
|
n/a
|
| O: 6.0%
H: 27.08%
C: 27.08%
bioscience offering
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.